Lv11
58 积分 2025-12-03 加入
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
30分钟前
已完结
S161 Tezepelumab reduces inflammatory biomarkers in adults with severe chronic rhinosinusitis with nasal polyps with and without comorbid asthma: results from the phase 3 WAYPOINT study
37分钟前
求助中
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
42分钟前
已完结
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
2天前
已完结
皖公网安备34019202002308
